Bicycle Therapeutics (BCYC) Current Assets (2018 - 2026)

Bicycle Therapeutics (BCYC) has 9 years of Current Assets data on file, last reported at $575.2 million in Q2 2026.

• Quarterly Current Assets fell 28.48% year-over-year to $575.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $575.2 million (down 28.48% YoY) and the FY2025 annual result came in at $682.9 million, down 26.46% from the prior year.
• Current Assets eased to $575.2 million in Q2 2026, from $619.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $1.0 billion in Q2 2024 to a low of $369.4 million in Q4 2022.
• A 5-year average of $625.5 million and a median of $589.1 million in 2023 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2024 — Current Assets jumped 151.76% — and 2026, when it slipped 28.48%.
• Tracing BCYC's Current Assets over 5 years: stood at $369.4 million in 2022, then surged by 52.11% to $561.9 million in 2023, then jumped by 65.27% to $928.6 million in 2024, then retreated by 26.46% to $682.9 million in 2025, then slipped by 15.76% to $575.2 million in 2026.
• The last three Current Assets figures came in at $575.2 million (Q2 2026), $619.1 million (Q1 2026), and $682.9 million (Q4 2025), per Business Quant data.